日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Bovine U3 small nucleolar ribonucleoprotein protein IMP4 (IMP4) CSB-YP609964BO
CSB-EP609964BO
CSB-BP609964BO
CSB-MP609964BO
CSB-EP609964BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine Vacuolar fusion protein CCZ1 homolog (CCZ1) CSB-YP609965BO
CSB-EP609965BO
CSB-BP609965BO
CSB-MP609965BO
CSB-EP609965BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Putative uncharacterized protein encoded by MIR22HG (MIR22HG) CSB-YP609966HU
CSB-EP609966HU
CSB-BP609966HU
CSB-MP609966HU
CSB-EP609966HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mouse Coiled-coil domain-containing protein 138 (Ccdc138) CSB-YP609967MO
CSB-EP609967MO
CSB-BP609967MO
CSB-MP609967MO
CSB-EP609967MO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus tropicalis Mitotic-spindle organizing protein 1 (mzt1) CSB-YP609968XBF
CSB-EP609968XBF
CSB-BP609968XBF
CSB-MP609968XBF
CSB-EP609968XBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus tropicalis Glutamyl-tRNA (Gln) amidotransferase subunit A, mitochondrial (qrsl1), partial CSB-YP609969XBF
CSB-EP609969XBF
CSB-BP609969XBF
CSB-MP609969XBF
CSB-EP609969XBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus tropicalis Uncharacterized protein C11orf87 homolog, partial CSB-YP609970XBF
CSB-EP609970XBF
CSB-BP609970XBF
CSB-MP609970XBF
CSB-EP609970XBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus tropicalis Mannose-1-phosphate guanyltransferase alpha (gmppa) CSB-YP609971XBF
CSB-EP609971XBF
CSB-BP609971XBF
CSB-MP609971XBF
CSB-EP609971XBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus tropicalis Protein FAM168B (fam168b), partial CSB-YP609972XBF1
CSB-EP609972XBF1
CSB-BP609972XBF1
CSB-MP609972XBF1
CSB-EP609972XBF1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio Selenoprotein S (sels), partial CSB-YP609973DIL1
CSB-EP609973DIL1
CSB-BP609973DIL1
CSB-MP609973DIL1
CSB-EP609973DIL1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus tropicalis DEP domain-containing protein 7 (depdc7), partial CSB-YP609974XBF
CSB-EP609974XBF
CSB-BP609974XBF
CSB-MP609974XBF
CSB-EP609974XBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus terreus Kynurenine 3-monooxygenase (bna4) CSB-YP609975APT
CSB-EP609975APT
CSB-BP609975APT
CSB-MP609975APT
CSB-EP609975APT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus terreus Pro-apoptotic serine protease nma111 (nma111), partial CSB-YP609976APT
CSB-EP609976APT
CSB-BP609976APT
CSB-MP609976APT
CSB-EP609976APT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus terreus WD repeat-containing protein ATEG_03285 (ATEG_03285), partial CSB-YP609977APT
CSB-EP609977APT
CSB-BP609977APT
CSB-MP609977APT
CSB-EP609977APT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus terreus Probable beta-glucosidase A (bglA), partial CSB-YP609978APT
CSB-EP609978APT
CSB-BP609978APT
CSB-MP609978APT
CSB-EP609978APT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus terreus Protein pxr1 (pxr1) CSB-YP609979APT
CSB-EP609979APT
CSB-BP609979APT
CSB-MP609979APT
CSB-EP609979APT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus terreus Eukaryotic translation initiation factor 3 subunit A (tif32), partial CSB-YP609980APT
CSB-EP609980APT
CSB-BP609980APT
CSB-MP609980APT
CSB-EP609980APT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus terreus Cyanate hydratase (cyn1) CSB-YP609981APT
CSB-EP609981APT
CSB-BP609981APT
CSB-MP609981APT
CSB-EP609981APT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus terreus Probable cutinase 4 (ATEG_02133) CSB-YP609982APT
CSB-EP609982APT
CSB-BP609982APT
CSB-MP609982APT
CSB-EP609982APT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus terreus Probable dipeptidyl-aminopeptidase B (dapB), partial CSB-YP609983APT
CSB-EP609983APT
CSB-BP609983APT
CSB-MP609983APT
CSB-EP609983APT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×